Status:

UNKNOWN

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

Lead Sponsor:

Al-Azhar University

Conditions:

Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

This prospective, comparative study is evaluating the effectiveness and adverse effects of using colistin at a loading dose of 9 million international units (MIU) followed by 4.5 MIU every 12 h (q12 h...

Eligibility Criteria

Inclusion

  • Patients with blood stream infection caused by MDR K. pneumoniae, as defined by Infectious Diseases Society of America (IDSA), who were hospitalised in the general ICU, confirmed with carbapenem-resistant K. pneumoniae-positive culture results from blood sample within the previous 5 days

Exclusion

  • All patients without a MDR carbapenem-resistant K. pneumoniae-positive culture isolated from the blood. In addition, the following patients are excluded: patients with a Glasgow Coma Scale (GCS) score of \<9 in non-ventilated patients or \<6 in ventilated patients; patients with end-stage metastatic malignant cancer; and all terminal patients with Acute Physiology and Chronic Health Evaluation (APACHE) II or Sequential Organ Failure Assessment (SOFA) scores of \>34 or \>15, respectively, and risk of mortality \>85% or \>80% on the first day of colistin administration, respectively \[27,28\]. Moreover, patients who received i.v. colistin combination therapies for \<72 h are excluded from further analysis

Key Trial Info

Start Date :

September 21 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04489459

Start Date

September 21 2019

End Date

July 1 2020

Last Update

July 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Qasr El Ainy

Cairo, Egypt